Stress reduction in the secondary prevention of cardiovascular disease: randomized, controlled trial of transcendental meditation and health education in Blacks.
Stress reduction in the secondary prevention of cardiovascular disease: randomized, controlled trial of transcendental meditation and health education in Blacks.
复制标题
DOI:
10.1161/circoutcomes.112.967406
复制
发表时间:
2012-11
期刊:
影响因子:
--
通讯作者:
Alexander CN
中科院分区:
文献类型:
--
作者:
Schneider RH;Grim CE;Rainforth MV;Kotchen T;Nidich SI;Gaylord-King C;Salerno JW;Kotchen JM;Alexander CN
African Americans have disproportionate rates of cardiovascular disease (CVD). Psychosocial stress may contribute to this disparity. Previous trials on stress reduction with the Transcendental Meditation (TM) program have reported improvements in CVD risk factors, surrogate endpoints and mortality in African Americans and other populations. This was a randomized controlled trial of 201 African American men and women with coronary heart disease (CHD) who were randomized to the TM program or health education. The primary end point was the composite of all-cause mortality, myocardial infarction, or stroke. Secondary endpoints included the composite of cardiovascular mortality, revascularizations, and cardiovascular hospitalizations; blood pressure (BP); psychosocial stress factors; and lifestyle behaviors. Over an average follow-up of 5.4 years, there was a 48% risk reduction in the primary end point in the TM group (hazard ratio [HR], 0.52; 95% confidence interval[CI], 0.29-0.92)(P =.025). The TM group also showed a 24% risk reduction in the secondary end point (HR, 0.76; 95% CI, 0.51-0.1.13) (P =.17). There were reductions of 4.9 mm Hg in systolic BP (95% CI −8.3 to –1.5 mm Hg) (P =.01) and anger expression (P < .05 for all scales). Adherence was associated with survival. A selected mind-body intervention, the Transcendental Meditation program, significantly reduced risk for mortality, myocardial infarction and stroke in CHD patients. These changes were associated with lower BP and psychosocial stress factors. Therefore, this practice may be clinically useful in the secondary prevention of CVD. www.clinicaltrials.gov;